2008 Annual Meeting | Acute Stroke Management
| 06:00 PM - 06:35 PM |
Medical, Lytic, Neuroprotective, and Endovascular Therapy of Acute Ischemic Stroke
Jeffrey L. Saver, MD, FÂ鶹´«Ã½Ó³» |
|
| 06:00 PM - 08:00 PM |
Reception
|
|
| 06:35 PM - 06:40 PM |
Questions and Answers
Jeffrey L. Saver, MD, FÂ鶹´«Ã½Ó³» |
|
| 06:40 PM - 07:15 PM |
Emergent Treatment of Intracerebral Hemorrhage: The New Framework
Joseph P. Broderick, MD, FÂ鶹´«Ã½Ó³» |
|
| 07:15 PM - 07:20 PM |
Questions and Answers
Joseph P. Broderick, MD, FÂ鶹´«Ã½Ó³» |
|
| 07:25 PM - 07:55 PM |
Primary and Secondary Stroke Centers: The Rubber Hits the Road
Mark J. Alberts, MD, FÂ鶹´«Ã½Ó³» |
|
| 07:55 PM - 08:00 PM |
Questions and Answers
Mark J. Alberts, MD, FÂ鶹´«Ã½Ó³» |
| Jeffrey L. Saver, MD, FÂ鶹´«Ã½Ó³» | Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical. |
| Joseph P. Broderick, MD, FÂ鶹´«Ã½Ó³» | The institution of Dr. Broderick has received research support from Novo Nordisk. Dr. Broderick has received publishing royalties from a publication relating to health care. |
| Mark J. Alberts, MD, FÂ鶹´«Ã½Ó³» | No disclosure on file |